1. Developing Treatments for Cancer
... new therapeutic approach on the growth inhibition of tumor cell lines. Gleevec was originally derived from a lead compound detected in a screening for inhibitors of protein kinase C (Capdeville et al.: 2002). The identified lead compound was observed to have a high potential for diversity and thus susceptible to chemical change to produce a compound greater in its effectiveness and selectivity for ... constitutive activation of signaling pathways, promote an increased efflux of the drug, and even generate plasma proteins that bind to the drug to decrease its concentration (Krause et al:...
- Word Count: 1146
- Approx Pages: 5
- Has Bibliography
- Grade Level: Graduate